US$ 22.35
glp-1 agonists and muscle loss Hidden Risks of Inhibitors: "Ozempic Face" The Influence of Glucagon-like Peptide-1
Description
Leipold G, Tth R, Hrsfalvi P, Lczi L, Trk M, Keszthelyi A, et al

229 Subsequently, evidence of the ileal-brake activity of GLP-1 was further provided using the GLP-1R antagonist exendin 9-39

ox-LDL: oxidized-LDL

doi:10.1016/j.cmet.2016.06.021 41